RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+2.66%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.41B
AUM Growth
+$6.41B
(+7.5%)
Cap. Flow
+$866M
Cap. Flow
% of AUM
13.52%
Top 10 Holdings %
Top 10 Hldgs %
42.9%
Holding
120
New
18
Increased
32
Reduced
17
Closed
9
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$375M |
| 2 |
QuidelOrtho
QDEL
|
$112M |
| 3 |
iTeos Therapeutics
ITOS
|
$57.7M |
| 4 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$51.7M |
| 5 |
PTC Therapeutics
PTCT
|
$50.8M |
Top Sells
| 1 |
Korro Bio
KRRO
|
$86.8M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$59.7M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$42.8M |
| 4 |
Penumbra
PEN
|
$20.7M |
| 5 |
Immunovant
IMVT
|
$19.8M |
Sector Composition
| 1 | Healthcare | 88.33% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Rocket Pharmaceuticals
RCKT
$354M
| $697M | 10.89% | 15,715,286 -1,344,925 | -8% | -$59.7M |
|
|
2
SPDR S&P 500 ETF Trust
SPY
$658B
| $375M | 5.85% | +946,255 | New | +$375M |
|
3
Vericel Corp
VCEL
$1.83B
| $251M | 3.92% | 4,517,570 | – | – |
|
|
4
PTC Therapeutics
PTCT
$3.92B
| $251M | 3.91% | 5,293,966 +1,072,130 | +25% | +$50.8M |
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $238M | 3.71% | 1,683,362 +1,717 | +0.1% | +$242K |
|
|
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $228M | 3.57% | 1,333,232 +278,868 | +26% | +$47.8M |
|
|
DRNA
7
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $191M | 2.98% | 7,463,291 +209,434 | +3% | +$5.36M |
|
8
Illumina
ILMN
$15.8B
| $185M | 2.89% | 481,956 +120,178 | +33% | +$46.2M |
|
9
Natera
NTRA
$23.1B
| $174M | 2.71% | 1,712,234 | – | – |
|
|
DMTK
10
DELISTED
DermTech, Inc. Common Stock
DMTK
| $158M | 2.47% | 3,118,665 +231,450 | +8% | +$11.8M |
|
11
Establishment Labs
ESTA
$1.2B
| $145M | 2.26% | 2,319,138 | – | – |
|
12
Stoke Therapeutics
STOK
$1.08B
| $142M | 2.21% | 3,644,248 +100,000 | +3% | +$3.88M |
|
13
Masimo
MASI
$7.59B
| $137M | 2.13% | 594,956 +125,540 | +27% | +$28.8M |
|
14
10x Genomics
TXG
$1.74B
| $129M | 2.01% | 711,515 +50,582 | +8% | +$9.16M |
|
|
CERN
15
DELISTED
Cerner Corp
CERN
| $128M | 1.99% | 1,774,485 +72,805 | +4% | +$5.23M |
|
|
AXNX
16
DELISTED
Axonics, Inc. Common Stock
AXNX
| $113M | 1.76% | 1,883,864 | – | – |
|
|
17
QuidelOrtho
QDEL
$1.95B
| $112M | 1.75% | +878,533 | New | +$112M |
|
18
Arvinas
ARVN
$568M
| $107M | 1.67% | 1,622,799 -168,197 | -9% | -$11.1M |
|
19
Globus Medical
GMED
$8.27B
| $103M | 1.61% | 1,670,811 +29,952 | +2% | +$1.85M |
|
|
20
Immunovant
IMVT
$2.56B
| $102M | 1.59% | 6,356,743 -1,235,510 | -16% | -$19.8M |
|
21
Tandem Diabetes Care
TNDM
$845M
| $101M | 1.57% | 1,139,230 +478,248 | +72% | +$42.2M |
|
|
22
iTeos Therapeutics
ITOS
| $94.4M | 1.47% | 2,762,791 +1,688,625 | +157% | +$57.7M |
|
23
Guardant Health
GH
$8.41B
| $93.1M | 1.45% | 609,774 +27,804 | +5% | +$4.24M |
|
24
Axsome Therapeutics
AXSM
$6.05B
| $91.5M | 1.43% | 1,616,497 -55,919 | -3% | -$3.17M |
|
25
Protagonist Therapeutics
PTGX
$3.67B
| $90.8M | 1.42% | 3,507,390 -142,679 | -4% | -$3.7M |
|